Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05548114 · ClinicalTrials.gov registry record · NA
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
A NA study of Gastric Outlet Obstruction, sponsored by Orlando Health.
- Active
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05548114 is a NA study of Gastric Outlet Obstruction that is active but no longer recruiting, run by Orlando Health. The registered enrollment target is 74 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05548114, a NA study of Gastric Outlet Obstruction, is active but no longer recruiting, sponsored by Orlando Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
Malignant gastric outlet obstruction (GOO) results from the mechanical obstruction of the duodenum or distal stomach from an underlying cancer. The aim of this study is to compare the clinical outcomes between surgical gastrojejunostomy and EUS-guided gastrojejunostomy in patients with malignant gastric outlet obstruction.
Conditions Studied
Interventions
- PROCEDURE EUS-guided gastrojejunostomy
- PROCEDURE Surgical gastrojejunostomy
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-09-16 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05548114
The ClinicalTrials.gov registry entry for NCT05548114 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastric Outlet Obstruction appearing as the primary indexed condition, and to 2 interventions - of which EUS-guided gastrojejunostomy is the first listed.
NCT05548114 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05548114 about?
NCT05548114 is a clinical study titled "Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction". Malignant gastric outlet obstruction (GOO) results from the mechanical obstruction of the duodenum or distal stomach from an underlying cancer. The aim of this study is to compare the clinical outcomes between surgical gastrojejunostomy and EUS-guided gastrojejunostomy in patients with malignant gas...
What is the current status of trial NCT05548114?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2022-09-16. Estimated completion is 2025-12.
What conditions does trial NCT05548114 study?
This clinical trial studies the following conditions: Gastric Outlet Obstruction.
What interventions are being tested in trial NCT05548114?
The interventions under investigation include: EUS-guided gastrojejunostomy (PROCEDURE), Surgical gastrojejunostomy (PROCEDURE).
Who is sponsoring clinical trial NCT05548114?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05548114 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.